论文部分内容阅读
急性感染性腹泻是儿科常见病之一,从世界范围来说,仍是一种令人担忧的疾病。据流行病学及人口统计学资料,76年婴儿中有5亿人发生腹泻,病死率1～4％,这样每年因腹泻死亡婴儿达500万至1,800万。近10年来,研究的成绩主要是阐明了急性感染性腹泻的主要病原体及它们的发病机理。此外,方便、有效的口服液体疗法已被公认为治疗腹泻的重要措施之一。本文重点简介近年来有关口服液疗在儿科的研究进展。
Acute infectious diarrhea is one of the most common pediatric diseases and remains a cause of concern worldwide. According to epidemiological and demographic data, 500 million people in 76 infants have diarrhea with a mortality rate of 1% to 4%, resulting in 5 million to 18 million infants who die from diarrhea each year. In the past 10 years, the research achievements mainly clarified the main pathogens of acute infectious diarrhea and their pathogenesis. In addition, convenient and effective oral liquid therapy has been recognized as one of the important measures to treat diarrhea. This article focuses on recent years, oral liquid therapy in pediatric research progress.